Authors: Pahernik, S Langer, S Botzlar, A Dellian, M Goetz, AE

Citation: S. Pahernik et al., Tissue distribution and penetration of 5-ALA induced fluorescence in an amelanotic melanoma after topical application, ANTICANC R, 21(1A), 2001, pp. 59-63

Authors: Dellian, M Yuan, F Trubetskoy, VS Torchilin, VP Jain, RK

Citation: M. Dellian et al., Vascular permeability in a human tumour xenograft: molecular charge dependence, BR J CANC, 82(9), 2000, pp. 1513-1518

Authors: Burkle, MA Pahernik, SA Sutter, A Jonczyk, A Messner, K Dellian, M

Citation: Ma. Burkle et al., Antiangiogenetic cancer therapy by inhibition of the integrin alpha(v)beta(3) using a cyclic peptide, LANG ARCH S, 1999, pp. 349-353

Authors: Pahernik, SA Peller, M Dellian, M Loeffler, R Issels, R Reiser, M Messmer, K Goetz, AE

Citation: Sa. Pahernik et al., Validation of MR thermometry technology: a small animal model for hyperthermic treatment of tumours, RES EXP MED, 199(2), 1999, pp. 59-71

Authors: Pahernik, SA Dellian, M Berr, F Tannapfel, A Wittekind, C Goetz, AE

Citation: Sa. Pahernik et al., Distribution and pharmacokinetics of Photofrin (R) in human bile duct cancer, J PHOTOCH B, 47(1), 1998, pp. 58-62

Authors: Sckell, A Safabakhsh, N Dellian, M Jain, RK

Citation: A. Sckell et al., Primary tumor size-dependent inhibition of angiogenesis at a secondary site: An intravital microscopic study in mice, CANCER RES, 58(24), 1998, pp. 5866-5869